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Effect of high protein diet on stone-forming propensity and
bone loss in rats.
Background. High protein diets are believed to cause kidney
stone formation and bone loss, but the mechanisms mediating
these changes are unknown. The purpose of this study was to
create an animal model of animal protein excess and to evaluate
the response of kidney and bone to the dietary protein load.
Methods. Rats (12 per group) were pair-fed with a high (48%)
and low (12%) casein diets that were otherwise identical in
their content of sodium, potassium, calcium, phosphorus, and
magnesium.
Results. Compared with the low casein group, the high ca-
sein group delivered a substantial acid load during 59 days of
study, since it significantly decreased urinary pH, and increased
urinary ammonium, titratable acidity, and net acid excretion.
Animals on high casein diet also had higher urinary volumes.
On the high casein diet, urinary calcium excretion was signif-
icantly higher and urinary citrate excretion and concentration
was significantly lower. On the high casein diet, urinary satu-
ration of calcium phosphate was higher. Serum calcitriol con-
centration did not significantly differ between the two groups.
Histomorphometric analysis of femur procured after 59 days
on the diet showed marked increase in bone resorption in the
high casein group. Hypocitraturia was associated with increased
activity of sodium-citrate cotransporter in renal cortical brush-
border membranes (BBM) in the high casein group.
Conclusion. Both the kidney and bone contribute to the
pathogenesis of hypercalciuria during high casein diet in rats.
Hypocitraturia is probably renal in origin. This rat model will be
useful in elucidating the mechanisms by which high protein in-
take increases the risk of nephrolithiasis and bone loss in human
beings.
The association of animal protein consumption with
kidney stone formation has long been recognized. A risk
analysis revealed that animal protein consumption carries
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increased risk for stone formation [1]. A recent random-
ized trial disclosed that that a diet restricted in animal
proteins and sodium was effective in controlling recur-
rent formation of calcium oxalate stones among patients
with hypercalciuria [2].
Two major factors cited for stone formation from an-
imal protein excess are hypocitraturia [3–6] and hyper-
calciuria [4, 6]. Hypocitraturia has been ascribed to the
acid load conferred by the high animal protein diet [5,
6]. Many schemes have been implicated for the develop-
ment of hypercalciuria from ingestion of animal proteins
spanning the three principal organs of calcium homeosta-
sis [7]. In the kidney, these include direct acid-mediated
impairment of renal tubular reabsorption of calcium [8],
altered renal handling of calcium from stimulation of
prostaglandin synthesis [9], changes in membrane phos-
pholipid content [10], and hyperfiltration of calcium from
increased renal parenchymal mass [11]. In the bowel, en-
hanced calcium absorption has been ascribed to stimu-
lated calcitriol synthesis from enlarged renal mass [11].
Another potential complication of high dietary intake of
animal proteins is bone loss. Bone loss has been attributed
to elaborating bone-resorbing cytokines [12]. Moreover,
acid load from animal protein excess may stimulate osteo-
clastic bone resorption, and inhibit osteoblastic collagen
synthesis [13].
We recently investigated metabolic effects of a weight-
reducing, high animal protein-low carbohydrate diet on
stone-forming propensity and bone metabolism in 10 nor-
mal subjects [6]. This diet delivered an acid load of about
50 mEq/day, reduced urinary citrate by 200 to 300 mg/day,
and increased urinary calcium by 90 to 100 mg/day. The
urinary saturation of calcium oxalate increased by about
35% and the estimated calcium balance turned less posi-
tive during the high protein diet, it was difficult in human
beings to ascertain the exact causes of hypercalciuria and
hypocitraturia, or to assess the state of bone turnover.
We therefore sought to create an animal model of
animal protein excess in rats. If successful, the animal
model will allow us to conduct appropriate studies to
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Table 1. Composition of high and low casein diets
Low Casein 12% High Casein 48%
Constituents g/kg g/kg
Casein 138 552
DL-Methionine 2.1 0
Corn starch 453 51
Sucrose 120 120
Maltodextrin 120 120
Soybean oil 66 63
Mineral mix, Ca-P deficient
(TD 79055)
13.37 13.37
Choline bitartrate 2.5 2.5
Calcium phosphate, dibasic
(CaHPO4)
13.71 1.011
Calcium carbonate 8.225 17.37
Sodium chloride 9.807 9.743
Potassium phosphate, dibasic
(K2HPO4)
1.838 1.813
Ferrous sulfate, FeSO4 - 7 H2O 0.325 0.315
Magnesium oxide, MgO 0.451 0.43
Kcal/100 g diet 371.44 369.22
% fat (by weight) 6.83 6.81
% calcium 0.7355 0.7356
% phosphorus 0.4413 0.4414
% sodium 0.4882 0.4882
% potassium 0.4629 0.4628
Magnesium ppm 782.1 781.8
unveil the underlying cellular-molecular basis for hypoc-
itraturia, hypercalciuria, stone-forming propensity, and
bone loss. In this communication, we describe studies in
rats fed a high casein diet as a model of animal protein
excess. These rats displayed marked hypercalciuria,
hypocitraturia, increased urinary saturation of calcium
phosphate, and pronounced bone loss on histomorpho-
metric analysis.
METHODS
Experimental protocol
Thirty-six (Sprague-Dawley) male rats, (8 weeks old,
average weight 232 g) (Charles River, Boston, MA, USA)
were randomized into two groups of 18 rats each re-
ceiving either low casein or high casein diets. The diets
were matched for sodium, potassium, phosphorus, cal-
cium, and magnesium (Table 1). The main difference be-
tween the two diets was in the sulfur content (1.57 g per
kg of low casein chow, and 3.34 g per kg of high casein
chow).
After 4 days of feeding (days 1 to 4) with high (48%)
or low (12%) casein diets, 12 rats from each group were
transferred to metabolic cages for pair feeding and urine
collection for 55 days (days 5 to 59). Rats were housed
individually. The high casein group was fed ad libitum
but the amount of food offered to the low casein group
was limited to the average intake of high casein group
from the previous day. Food was provided at 10:00 a.m.
each day. All animals were given distilled water ad libi-
tum for the duration of the study. Weight and urine vol-
ume were recorded for all animals on each day of urine
collection.
Urine collection for biochemical analysis. On days 11
and 12, 19 and 26, 40 and 47, and 55 and 59, a 24-hour
urine sample from each animal was collected under
3 mL of mineral oil and 5 crystals of thymol. Urine sam-
ples were transferred into graduated centrifuge tubes and
urine volumes were recorded.
Biochemical analysis in serum, and studies in kidney
tissue. On day 60 (after 59 days on the respective di-
ets), all 24 rats (12 on low casein and 12 on high casein
diets) in metabolic cages were sacrificed. Blood was
drawn from the inferior vena cava for biochemical analy-
sis. Kidneys were harvested for sodium citrate cotrans-
porter (NaDC-1) activity in brush-border membranes
(BBM).
Harvesting of bone. After 4 days of feeding with high
(48%) or low (12%) casein diet, the remaining six rats
from each group were pair-fed according to the above-
mentioned protocol for 55 days. A 70% ethanol solution
containing 300 mg tetracycline/mL was prepared and was
kept in a glass tube wrapped in aluminum in the dark.
Prior to use it was diluted 1:10 in a saline solution buffered
with phosphate to pH 7.4 resulting in a working solution
of 30 mg tetracycline/mL. Rats were injected intraperi-
toneally with tetracycline (30 mg per kg body weight) on
days 45 and 46, and again on days 55 and 56. On day 60
(after completion of 59 days on the diet), animals were
sacrificed. Femora were harvested and stored for bone
histomorphometric analysis.
BBM isolation. After the kidneys were removed,
they were placed in an iced-cold buffer solution (pH
7.5) (in mmol/L) [300 mannitol, 5 ethylene glycol-
bis(b-aminoethyl ether)-N,N,N′,N′-tetraacetic acid
(EGTA), 0.1 phenylmethyl sulfonylfluoride, and 18
tris(hydroxymethyl) aminomethane (Tris)]. Thin super-
ficial cortical slices were homogenized with a polytron
homogenizer, and the BBM vesicles were isolated by
differential centrifugation and magnesium precipitation
as previously described [18]. The final BBM fraction was
washed twice, and the final pellet was resuspended in a
buffer solution (pH 7.5) (in mmol/L) [200 mannitol, 50
KCl, 6 N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic
acid (Hepes), and 10 Tris].
Analytic methods
Biochemical analysis. Urinary sodium and potassium
were analyzed by flame photometry, and calcium and
magnesium by atomic absorption spectrophotometry.
Phosphorus, creatinine, ammonium and citrate were
measured by autoanalyzer (Cobas MIRA) (Roche Di-
agnostics, Inc., Montclair, NJ, USA). Oxalate and sul-
fate were determined by ion chromatography (Dionex
2001) (Dionex, Sunnydale, CA, USA). Titratable acidity
was determined by titrating the urine sample to pH 7.4
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with 0.1 N sodium hydroxide. Serum chemistries were
obtained by using an autoanalyzer. Serum parathyroid
hormone (PTH) as assayed with immunoradiometric as-
say (IRMA) kit (Nichols Institute, San Juan Capistrano,
CA, USA). Serum 1,25-(OH)2 vitamin D (calcitriol) was
analyzed by the method previously described [14].
Net acid excretion was obtained (in mEq/day) as [titrat-
able acidity + ammonium] – [bicarbonate – citrate2−/3−].
Urinary citrate was included in this equation because cit-
rate2−/3− is a legitimate urinary base. Urinary saturation
of calcium oxalate and brushite (CaHPO4·2 H2O) was es-
timated from relative saturation ratio (RSR), or the ratio
of activity product of calcium oxalate or brushite and the
respective thermodynamic solubility product [15]. A ra-
tio of 1 indicated saturation, >1 supersaturation, and <1
undersaturation.
Histomorphometric analysis. Bone histomorphometry
was performed on the distal metaphysis of the left femur
from each rat after double tetracycline labeling. After
removing the entire femur, the distal half was placed in
Villanueva osteochrome (Polysciences, Warrington, PA,
USA) for 72 hours. The specimen was then dehydrated
in a graded series of alcohol and processed undecalcified
in methylmethacrylate as previously described [16]. Ten
micron sections were obtained in the longitudinal plane.
The histomorphometric examination was performed at
the computer monitor on images captured from an Aus
Jena microscope with an Optiplex video camera attach-
ment. The bone histomorphometry software (Bioquant
Nova II) (R&M Biometrics, Nashville, TN, USA) per-
mitted quantitation of areas, lengths, and individual dis-
tances. Static measurements of cancellous bone volume
and thickness and cellular parameters were made on tolu-
idine blue–stained sections. Fluorochrome-based indices
of bone formation were measured in unstained sections.
Measurements of cancellous bone were taken at a dis-
tance of at least 1 mm from the growth plate to prevent
inclusion of the primary spongiosa. The terminology used
is that recommended by the histomorphometry nomen-
clature committee of the American Society for Bone and
Mineral Research [17].
BBM citrate transport measurements. Citrate transport
activity measurements were performed in freshly isolated
BBM vesicles by the radiotracer uptake using the rapid
Millipore rapid filtration technique (Millipore, Bedford,
MA, USA) as previously described [19, 20]. Uptake was
initiated by vortex mixing 100 lg protein of BBM vesi-
cles preloaded with intravesicular buffer (in mmol/L)
(200 mannitol, 50 KCl, 16 Hepes, and 10 Tris, pH 7.5)
with a 5 volume excess of uptake solution (in mmol/L)
100 NaCl, 50 KCl, 16 Hepes, 10 Tris, pH 7.50, and
0.1 14C-citrate). For Na+-independent uptake, NaCl in
the uptake solution was replaced by choline chloride.
Transport was terminated by ice-cold stop solution (in
mmol/L) (135 NaCl, 10 Na succinate, 16 Hepes, and 10
Tris, pH 7.5) and then rapidly filtered through a presoaked
0.65 lm pore-size cellulose nitrate filter (DAWP 02500)
(Millipore) under vacuum suction. Filter blanks were de-
termined similarly by adding the ice-cold stop solution to
BBM vesicles simultaneously with the uptake solution.
All uptake measurements were performed at 25◦C in trip-
licate, and uptake was calculated as picomoles citrate per
time interval per milligram BBM protein.
Statistical analysis
Differences between the high and low casein diets were
assessed using two-factor repeated measures analysis of
variance (ANOVA) for urinary determinants of acid-
base status and stone risk factors. A between group fac-
tor (two casein groups) and a repeated factor (different
study days) were included in the model. Comparisons of
two diets at each time period were derived from the anal-
ysis of variance model. Significant difference in histomor-
phometric indices between the two diets was assessed by
Wilcoxon rank sum test. Significant difference between
the two diets in serum biochemistry, endogenous creati-
nine clearance and BBM transport was assessed by Stu-
dent t test. Results are presented as mean and standard
deviation. Statistical analysis was performed with SAS
version 8.2 (SAS Institute, Cary, NC, USA).
RESULTS
Diet consumption, body weight, and urine collection
During 59 days of study in metabolic cages, food con-
sumption gradually declined in both groups (N = 12 in
each group). In the high casein group, mean food con-
sumption was 21.7 g/day on days 11 and 12, 20.0 g/day
on days 19 and 26, 17.6 g/day during days 40 and 47, and
15.6 g/day on days 55 and 59. In the low casein group,
mean food consumption was 22.0 g/day during days 11
and 12, 20.5 g/day during days 19 and 26, 16.5 g/day
during days 40 and 47, and 15.4 g/day during days 55
and 59.
After 4 days on casein diets, average body weight be-
fore pair-feeding was 236 g in the high casein group and
231 g in the low casein group. In both diet groups, body
weight gradually increased during the study. In the high
casein group, mean body weight was 293 g on days 11
and 12, 352 g on days 19 and 26, 430 g on days 40 and
47, and 444 g on days 55 and 59. In the low casein group,
mean body weight was 276 g on days 11 and 12, 339 g on
days 19 and 26, 402 g on days 40 and 47, and 404 g on
days 55 and 59. There is a trend for higher body weight
in the high casein group but the differences between the
two diet groups at corresponding time periods were not
statistically significant.
Twenty-four–hour urine collections were made at the
indicated times. Urine volumes were higher in the high
casein group at all time points (Table 4). Total urinary
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Table 2. Measures of acid-base status during low and high casein
diets
Days on the diet
11 and 12 19 and 26 40 and 47 55 and 59
Urinary pH
Low casein 6.97 ± 0.36 7.34 ± 0.47 6.92 ± 0.19 7.34 ± 0.16
High casein 6.14 ± 0.22a 6.25 ± 0.22a 6.21 ± 0.13a 6.24 ± 0.13a
Urinary sulfate mmol/day
Low casein 0.28 ± 0.04 0.29 ± 0.03 0.36 ± 0.07 0.20 ± 0.04
High casein 1.54 ± 0.35a 1.59 ± 0.30a 1.69 ± 0.19a 1.36 ± 0.33a
Urinary ammonium mEq/day
Low casein 0.50 ± 0.14 0.84 ± 0.47 0.58 ± 0.11 0.56 ± 0.47
High casein 2.71 ± 0.70a 2.81 ± 0.77a 2.90 ± 0.36a 2.32 ± 0.42a
Titratable acidity mEq/day
Low casein 0.04 ± 0.04 0.01 ± 0.01 0.06 ± 0.04 0.02 ± 0.01
High casein 0.51 ± 0.21a 0.68 ± 0.20a 0.64 ± 0.15a 0.52 ± 0.17a
Net acid excretion mEq/day
Low casein −0.14 ± 0.19 −0.41 ± 1.27 0.25 ± 0.18 0.24 ± 0.45
High casein 2.99 ± 0.87a 3.29 ± 0.74a 3.43 ± 0.39a 2.77 ± 0.52a
All values are expressed as mean ± SD.
aP < 0.001 for significant difference between the two diets. In this table as well
as in Table 4, the average of two determinations obtained during 2 days of each
time period was taken for each rat in calculating the group mean.
creatinine was higher in the casein group on days 19
through 59 (not shown). Creatinine normalized per body
weight was numerically higher in the high casein group
but was not significantly different between the two groups
(low casein vs. high casein in mg/kg, mean ± SE): 29.7 ±
2.9 vs. 31.7 ± 7.2 on days 11 and 12; 24.2 ± 2.4 vs. 28.1 ±
2.5 on days 19 and 26; 30.8 ± 2.5 vs. 36.1 ± 4.0 on days 40
and 47; and 23.8 ± 4.7 vs. 30.4 ± 2.9 on days 55 and 59.
Acid-base parameters
The effect of high casein diet on indices of acid-base
balance is shown in Table 2. Urinary pH was signifi-
cantly lower, and urinary sulfate, ammonium, and titrat-
able acidity were significantly higher on high casein diet
compared with the low casein diet. Net acid excretion
(NAE) was low on the low casein diet. On the high ca-
sein diet, it was higher by 2.5-fold to 3.7-fold (Table 2).
Note that the increase in NAE (∼3 mEq/day) exceeded
the increase in urinary sulfate excretion (∼2.4 mEq/day)
induced by the high casein diet. Urinary bicarbonate was
(mean ± SE in mEq/day low casein vs. high casein)
0.15 ± 0.12 vs. 0.05 ± 0.03 (days 11 and 12), 0.90 ± 1.56
vs. 0.07 ± 0.10 (days 19 and 26), 0.10 ± 0.10 vs. 0.04 ± 0.01
(days 40 and 47), and 0.20 ± 0.09 vs. 0.03 ± 0.01 (days 55
and 59). Serum sodium, chloride, bicarbonate, and anion
gap obtained on the day of sacrifice (day 60 after 59 days
on the diet) did not differ significantly between high and
low casein diets (Table 3). However, serum potassium
was significantly lower on the high casein diet.
Stone risk factors
Key urinary stone risk factors are presented in Tables 4
and 5. On both diets, each stone risk factor tended to de-
cline as the study progressed. However, at each time pe-
Table 3. Serum biochemistry during low and high casein diets on
day 60
Low casein High casein
Serum
Sodium mEq/L 135 ± 2 138 ± 1
Potassium mEq/L 6.95 ± 1.18 5.53 ± 0.38a
Chloride mEq/L 99 ± 1 101 ± 1
Bicarbonate mEq/L 22.8 ± 1.7 23.6 ± 2.4
Calcium mg/dL(mmol/L) 9.8 ± 0.3 9.7 ± 0.3
(2.45 ± 0.07) (2.42 ± 0.07)
Phosphorus mg/dL (mol/L) 7.5 ± 0.7 7.1 ± 0.3
(2.42 ± 0.23) (2.29 ± 0.10)
PTH pg/mL 76 ± 57 44 ± 17
Calcitriol ng/mL 60 ± 22 52 ± 12
PTH is parathyroid hormone.
All values are expressed as mean ± SD. Serum electrolytes, calcium, and
phosphorus were determined in 12 rats from each group. However, serum PTH
and calcitriol could be analyzed in only 10 rats on low casein diet, and 9 rats on
high casein diet.
aP < 0.01 between the two diets.
riod, urinary excretion of calcium, phosphorus, and mag-
nesium were significantly higher, and urinary citrate was
significantly lower, during the high casein diet than on the
low casein diet (Table 4). Throughout the study, urinary
calcium excretion remained 2.7-fold to 3.6-fold higher in
the high casein group (Fig. 1 and Table 4). Because of
the higher urinary volume, urinary calcium concentra-
tion was not significantly higher on the high casein diet
(Table 5). Urinary citrate excretion in the high casein
group was 61% to 78% lower than in the low casein group
(Fig. 1 and Table 4). Urinary citrate concentration in the
high casein group was only 11% of that of the low casein
group (Table 5). Urinary phosphate excretion was 5- to
14-fold higher (Table 4) and urinary phosphate concen-
tration was 2- to 6-fold higher (Table 5) in the high casein
group. In contrast, there was no significant difference in
urinary oxalate excretion (Table 4). There was no differ-
ence in sodium, or potassium excretion between the two
diets (not shown).
When saturations were analyzed using concentrations
(Table 5), calcium oxalate urinary saturation remained
relatively stable and was not higher in the high casein diet.
In fact, on days 55 and 59, calcium oxalate was actually
slightly but significantly lower in the high casein group.
The saturation of brushite was constant and remained
consistently higher in the high casein group (Table 5).
Indices of calcium metabolism and creatinine clearance
There was no significant difference in serum calcium,
phosphorus, PTH, and calcitriol between high and low
casein diets (Table 3). However, endogenous creatinine
clearance was significantly higher in the high casein group
(0.015 mL/min vs. 0.026 mL/min, P < 0.01).
Histomorphometric findings
Bone histomorphometric findings are summarized in
Table 6. There were no significant differences between
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Table 4. Urinary stone risk factors: Low vs. high casein diets (excretion rates)
Days on the diet
11 and 12 19 and 26 40 and 47 55 and 59
Calcium mg/day (mmol/day)
Low casein 1.00 ± 0.83 0.76 ± 0.41 0.74 ± 0.42 0.63 ± 0.37
(0.025 ± 0.021) (0.019 ± 0.010) (0.018 ± 0.010) (0.016 ± 0.009)
High casein 3.59 ± 1.83a 3.05 ± 1.58a 1.98 ± 0.98b 1.95 ± 0.90b
(0.090 ± 0.046) (0.076 ± 0.039) (0.049 ± 0.024) (0.049 ± 0.022)
Oxalate mg/day (lmol/day)
Low casein 0.52 ± 0.11 0.58 ± 0.10 0.50 ± 0.09 0.36 ± 0.10
(5.8 ± 1.2) (6.4 ± 1.1) (5.6 ± 1.0) (4.0 ± 1.1)
High casein 0.49 ± 0.12 0.45 ± 0.07 0.39 ± 0.13 0.30 ± 0.06
(5.4 ± 1.3) (5.0 ± 0.8) (4.3 ± 1.4) (3.3 ± 0.7)
Phosphorus mg/day (mmol/day)
Low casein 4.0 ± 1.7 1.4 ± 1.0 4.6 ± 1.7 2.4 ± 0.9
(0.13 ± 0.05) (0.05 ± 0.03) (0.15 ± 0.05) (0.08 ± 0.03)
High casein 21.2 ± 6.3a 24.3 ± 6.0a 22.0 ± 3.4a 17.4 ± 4.2a
(0.68 ± 0.20) (0.78 ± 0.19) (0.71 ± 0.11) (0.56 ± 0.14)
Citrate mg/day (mmol/day)
Low casein 48.8 ± 12.4 32.6 ± 6.2 26.5 ± 8.0 12.4 ± 5.7
(0.25 ± 0.06) (0.17 ± 0.03) (0.14 ± 0.04) (0.06 ± 0.03)
High casein 15.2 ± 6.4a 10.3 ± 5.2a 5.8 ± 2.5a 3.6 ± 1.1b
(0.08 ± 0.03) (0.05 ± 0.03) (0.03 ± 0.01) (0.02 ± 0.01)
Magnesium mg/day (mmol/day)
Low casein 5.10 ± 1.08 3.45 ± 1.33 2.52 ± 0.92 1.70 ± 0.89
(0.210 ± 0.044) (0.142 ± 0.055) (0.104 ± 0.038) (0.070 ± 0.037)
High casein 6.84 ± 1.61a 7.00 ± 1.48a 6.48 ± 0.98a 4.79 ± 0.94a
(0.281 ± 0.066) (0.288 ± 0.061) (0.267 ± 0.040) (0.197 ± 0.039)
Urinary volume mL/day
Low casein 11 ± 3 12 ± 4 10 ± 2 8 ± 3
High casein 33 ± 9c 29 ± 7c 26 ± 4c 20 ± 4b
All values are expressed as mean ± SD.
aP < 0.001; bP < 0.01; cP < 0.05 between two diets. The mean value of 18 mL for all samples from all rats was taken in calculating relative saturation ratio (RSR).
the high and low casein groups for any of the bone histo-
morphometric parameters except for the measurements
of bone resorption (BS), namely eroded surface (ES) and
osteoclastic surface (OcS). There were marked and signif-
icant increases in both of these parameters for the rats on
the high casein diet. High casein diet increased eroded
surface (ES/BS) threefold (6.5% ± 1.22% vs. 19.6% ±
1.79%, P < 0.001) and osteoclastic surface (OcS/BS)
3.3-fold (2.3% ± 0.48% vs. 7.7% ± 0.97%, P < 0.01).
Mean values for osteoid indices (osteoid volume, osteoid
surface, and osteoblastic surface) were not significantly
different.
BBM NaDC-1 activity
BBM transport of citrate in the high casein group
was higher than in the low casein group (213 vs. 133
pmol/second/mg BBM protein, P < 0.01) (Fig. 2). BBM
transport of sulfate, serving as the control for citrate trans-
port, showed no significant difference between high and
low casein groups (P = 0.8).
DISCUSSION
This study was undertaken in order to determine if a
high casein diet in rats could serve as a model to study the
effect of high animal protein diet on mineral metabolism.
Compared to rats kept on a low casein diet, rats on a high
casein-fed showed a much higher net acid excretion, uri-
nary calcium and phosphate, and a much lower urinary
citrate excretion rate. Urinary saturation of calcium ox-
alate did not increase due to the higher urinary volumes
in the high casein diet. Brushite saturation increased
markedly throughout the whole study. Urinary citrate ex-
cretion and concentration were both markedly reduced.
No kidney stones or nephrocalcinosis were noted by gross
examination in this group of animals.
Note that the high casein diet-induced increase in uri-
nary phosphate exceeded that of calcium consistently in
all time points. Both bone phosphate release and acid-
induced renal phosphaturia can account for some of the
phosphaturia. However, it is more likely that there is
more organic phosphorus in the high casein diet. This is
compatible with the fact that the high casein-induced in-
crement in NAE (mean  = 3.13 mEq/day) exceeded the
increment in sulfate excretion (mean = 2.52 mEq/day),
suggesting that part of the acid load in the high casein diet
was derived from nonsulfur containing amino acids such
as phosphoserines and phosphothreonines.
Rats on the high casein diet had much higher urinary
volumes. The etiology of this is not established but may be
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Table 5. Urinary stone risk factors: Low vs. high casein diets
(concentrations)
Days on the diet
11 and 12 19 and 26 40 and 47 55 and 59
Calcium mg/L (mmol/L)
Low casein 92 ± 81 65 ± 34 74 ± 31 79 ± 21
(2.3 ± 2.0) (1.6 ± 0.8) (1.9 ± 0.8) (2.0 ± 0.5)
High casein 108 ± 45 101 ± 46 77 ± 37 97 ± 35
(2.7 ± 1.1) (2.5 ± 1.1) (1.9 ± 0.9) (2.4 ± 0.9)
Oxalate mg/L (lmol/L)
Low casein 48 ± 13 52 ± 16 54 ± 16 52 ± 23
(0.53 ± 0.14) (0.58 ± 0.17) (0.60 ± 0.17) (0.58 ± 0.26)
High casein 15 ± 3a 16 ± 3a 15 ± 5a 16 ± 3a
(0.17 ± 0.03) (0.18 ± 0.04) (0.17 ± 0.06) (0.17 ± 0.03)
Phosphorus mg/L (mmol/L)
Low casein 369 ± 199 137 ± 144 487 ± 160 340 ± 144
(11.9 ± 6.4) (4.4 ± 4.7) (15.7 ± 5.2) (11.0 ± 4.6)
High casein 641 ± 124a 828 ± 120a 873 ± 161a 893 ± 151a
(20.7 ± 4.0) (26.7 ± 3.9) (28.2 ± 5.2) (28.8 ± 4.9)
Citrate mg/L (mmol/L)
Low casein 4473 ± 1380 2964 ± 1148 2818 ± 948 1712 ± 758
(23.5 ± 7.3) (15.6 ± 6.0) (14.8 ± 5.0) (9.0 ± 4.0)
High casein 479 ± 199a 356 ± 158a 237 ± 124a 185 ± 57a
(2.5 ± 1.0) (1.9 ± 0.8) (1.2 ± 0.7) (1.0 ± 0.3)
Magnesium mg/L (mmol/L)
Low casein 467 ± 129 315 ± 161 255 ± 67 219 ± 91
(19.2 ± 5.3) (12.9 ± 6.6) (10.5 ± 2.8) (9.0 ± 3.7)
High casein 213 ± 55a 242 ± 47 260 ± 60 219 ± 91
(8.8 ± 2.3) (10.0 ± 1.9) (10.7 ± 2.5) (9.0 ± 3.7)
RSR, calcium oxalate
Low casein 2.09 ± 1.67 2.27 ± 1.11 2.42 ± 1.10 3.54 ± 1.23
High casein 2.71 ± 1.01 2.40 ± 1.02 1.77 ± 1.01 2.24 ± 0.81b
RSR, brushite
Low casein 0.50 ± 0.57 0.16 ± 0.09 0.60 ± 0.37 0.74 ± 0.40
High casein 1.62 ± 0.61a 2.07 ± 0.85a 1.70 ± 0.91a 2.23 ± 0.88a
RSR is relative saturation ratio. All values are expressed as mean ± SD.
aP < 0.001; bP < 0.01 between two diets.
secondary to a higher osmolar load from the high protein
diet driving higher urine volumes and stimulating thirst.
Unfortunately, urinary urea and osmoles were not avail-
able from this set of data to confirm this hypothesis. It is
unknown whether a higher urine volume accompanies a
high protein diet in humans, particularly when the pro-
tein load is of much lower magnitude than the current
study in rats.
In a recent study [6], human beings maintained on a
weight-reducing, high protein low carbohydrate diet re-
vealed qualitatively similar but quantitatively less promi-
nent changes. In human beings kept on a high protein low
carbohydrate diet with a mean body weight of 81 kg [6],
net acid excretion increased by about 50 mEq/day. In this
study of rats weighing between 240 to 440 g, net acid ex-
cretion increased by 2.5 to 3.7 mEq/day on the high casein
diet. In human subjects kept on a high protein low car-
bohydrate diet [6], net acid excretion increased by 80%
to 90%. In this study, net acid excretion was 2.5-fold to
3.7-fold higher among rats fed a high casein diet than on
the low casein diet. The most likely explanation for the
different responses between human beings and rats is the
different magnitude of acid load delivered.
From the standpoint of their pathogenetic role in stone
formation and bone loss, key biochemical disturbances
produced by a high casein or animal protein diet are
hypocitraturia and hypercalciuria. Hypocitraturia can
predispose to the formation of calcium-containing stones
since citrate is one of the well-recognized inhibitors of
the crystallization of calcium oxalate and calcium phos-
phate [21]. Hypercalciuria contributes to stone formation
by increasing urinary saturation of calcium salts [22] and
by binding negatively charged inhibitors of stone forma-
tion [23]. Hypercalciuria partially results from bone loss.
Bone loss occurred during a high casein diet, as evident by
marked increase in bone resorption on histomorphomet-
ric analysis. Although numerically, there was some trend
toward lower bone formation, none of the difference for-
mation parameters were statistically significant. Note that
these animals continued to grow despite the high acid
load and bone abnormalities compared to young humans
with renal tubular acidosis who have stunted growth. One
possible explanation is that the high acid load from di-
etary protein is within the acid-excreting capacity of the
kidney resulting in preserved plasma acid-base parame-
ters. In contrast, individuals with renal tubular acidosis
have impaired renal acidification and abnormal plasma
pH and bicarbonate.
There is general agreement that hypocitraturia is renal
in origin, attributable to the acid load conferred by the
animal protein diet. Clinically, hypocitraturia has been
encountered in acquired metabolic acidosis of chronic di-
arrheal syndrome [24], distal renal tubular acidosis [25],
and dietary animal protein consumption [3]. Hypocitra-
turia is readily ameliorated by administration of potas-
sium alkali [25]. At the cellular level, proximal tubule
reabsorption of citrate is coupled to sodium, mediated
by the NaDC-1 cotransporter. Reabsorbed citrate is then
metabolized within cytoplasm via adenosine triphosphate
(ATP)-citrate lyase [26] or within mitochondria via the
citric acid cycle. Chronic metabolic acidosis causes hypoc-
itraturia by stimulating the activity of NaDC-1, ATP-
citrate lyase and phosphoenolpyruvate carboxykinase
(which metabolizes cytoplasmic oxalacetate generated
from citrate) [27]. In contrast to the previous studies [26,
27], the acid load in this study was not sufficient to cause
detectable systemic acidosis, but yet we found increase
NaDC-1 activity in renal BBM in the high casein-fed rats.
Hypocitraturia associated with high casein diet is there-
fore at least in part related to the increased activity of
NaDC-1 cotransporter occurring as an adaptive response
to the acid load.
Hypercalciuria associated with high casein diet is un-
likely to be intestinal in origin. Although intestinal
calcium absorption was not directly measured, serum
calcitriol concentration was marginally lower on the
high casein diet, arguing against the scheme implicat-
ing stimulation of calcitriol synthesis from enlarged renal
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Fig. 1. Comparison of urinary calcium (A) and citrate (B) between high casein and low casein diets. Bars indicate mean + SD. Significant difference
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Table 6. Bone histomorphometry during low and high casein diets
Low casein diet High casein diet
Histomorphometric index (N = 6) (N = 6)
Trabecular thickness lm 53 ± 6 50 ± 3
OV/BV% 1.2 ± 1.0 0.5 ± 0.6
OS/BS% 3.1 ± 1.1 2.4 ± 1.7
ObS/BS% 2.1 ± 1.0 1.6 ± 1.1
ES/BS% 6.5 ± 3.0 19.6 ± 4.4a
OcS/BS% 2.3 ± 1.2 7.7 ± 2.4b
MS/BS% 9.2 ± 2.2 10.1 ± 1.9
MAR lm/day 1.1 ± 1.4 1.6 ± 1.0
Abbreviations are: OV/BV, osteoid volume/bone volume; OS/BS, osteid
surface/bone surface; ObS/BS, osteoblastic surface/bone surface; ES/BS, eroded
surface/bone surface; OcS/BS, osteoclastic surface/bone surface; MS/BS, miner-
alized surface expressed as one-half single-labeled surface plus double-labeled
surface/bone surface; MAR, mineral apposition rate.
aP < 0.001; bP < 0.01 are significant difference between high and low casein
diets. All values expressed as mean ± SD.
parenchymal mass [11]. Bone loss was indicated by a sub-
stantial increase in osteoclastic bone resorption by about
threefold on histomorphometric analysis. Bone loss must
contribute to the pathogenesis of hypercalciuria. It is un-
clear from this study whether bone loss is directly the
result of acid load itself [12], or occurs secondarily
from release of bone-resorbing prostaglandins [28] or
cytokines [12].
In addition to calcium release from bone, altered re-
nal handling of calcium must also be involved in the
development of hypercalciuria from high animal pro-
tein diet. Since there was no change in systemic pH or
calcium concentration, the filtered load of calcium, esti-
mated from changes in creatinine clearance, was higher
in the high casein-fed rats than in low casein-fed rats by
73%. However, urinary calcium excretion was greater
by 2.7-fold to 3.6-fold in the high casein group. Clin-
ically, urinary calcium excretion is directly correlated
with net acid excretion [29], and treatment with potas-
sium alkali reduces urinary calcium excretion [30–32],
commensurate with a reduction in net acid excretion. In
dogs, metabolic acidosis has been shown to impair the
renal tubular transport of calcium by micropuncture and
renal clearance [8]. Exact cellular-molecular mechanisms
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of this acid-induced renal calcium leak remain to be
elucidated.
It is noteworthy that many of the urinary biochemical
factors showed a gradual decline in their daily excretion
rates during the 59 days on casein diets. In part, this de-
cline may reflect reduced intake of food. It may also re-
flect adaptive mechanisms, the nature of which requires
elucidation.
CONCLUSION
A high casein diet in rats delivering a three- to fourfold
increase in net acid, may serve as an ideal animal model to
study cellular-molecular mechanisms for hypocitraturia,
hypercalciuria, and bone loss associated with animal pro-
tein consumption.
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